5.1 Intracerebral Hemorrhage Pathophysiology, ICH Score & Acute Management

Intracerebral Hemorrhage Pathophysiology, ICH Score & Acute Management

Intracerebral hemorrhage (ICH) accounts for approximately 10% to 15% of all strokes but is associated with the highest mortality rate, with a 30-day mortality approaching 40% to 50%. The primary injury in ICH occurs rapidly, often over minutes to hours, as blood escapes from a ruptured vessel directly into the brain parenchyma. This sudden accumulation of blood acts as a space-occupying lesion, displacing and compressing adjacent brain tissue. This initial mechanical disruption and pressure lead directly to neuronal damage, necrosis, and the tearing of surrounding white matter tracts. The mass effect generated by the hematoma can also compromise local microcirculation, worsening the overall ischemic burden on the brain.

Pathophysiology of ICH

Following the primary injury, a secondary injury cascade is initiated, largely driven by the presence of intraparenchymal blood and its breakdown products. The formation of a hematoma is followed by clot retraction and the subsequent release of serum proteins and osmotically active molecules into the surrounding tissue. Red blood cells within the clot eventually undergo lysis, releasing hemoglobin. Hemoglobin is then degraded into heme, iron, and other reactive oxygen species. Free iron is highly toxic to brain tissue; it catalyzes the production of free radicals through the Fenton reaction, leading to lipid peroxidation, DNA damage, and widespread cellular apoptosis.

Moreover, the inflammatory response plays a critical role in secondary injury. Microglia, the resident immune cells of the central nervous system, are rapidly activated and migrate to the hematoma margins. While they help in phagocytosing cellular debris and red blood cells, their hyperactivation leads to the release of pro-inflammatory cytokines (such as TNF-alpha and IL-1 beta), matrix metalloproteinases, and chemokines. These mediators exacerbate blood-brain barrier (BBB) disruption and perihematomal edema (PHE). Vasogenic edema typically peaks around 5 to 6 days post-hemorrhage but can persist for several weeks. This progressive edema significantly increases intracranial pressure (ICP), potentially leading to devastating consequences such as uncal or central herniation.

The most common cause of spontaneous ICH is hypertensive vasculopathy, which classically affects the deep penetrating arteries of the brain. Chronic hypertension leads to lipohyalinosis and the formation of Charcot-Bouchard microaneurysms in small vessels such as the lenticulostriate arteries. Consequently, hypertensive ICH most frequently occurs in the basal ganglia, thalamus, pons, and cerebellar hemispheres. In older adults, cerebral amyloid angiopathy (CAA) is a leading cause of lobar ICH. CAA is characterized by the deposition of beta-amyloid protein in the media and adventitia of small- to medium-sized cortical and leptomeningeal arteries, making them extremely fragile and prone to spontaneous rupture. Other causes include coagulopathies, hemorrhagic transformation of an ischemic stroke, and underlying vascular anomalies.

The ICH Score

The ICH Score is a widely used clinical grading scale that provides a simple, rapid, and reliable method for predicting 30-day mortality in patients with spontaneous intracerebral hemorrhage. The score ranges from 0 to 6, with higher scores indicating a progressively worse prognosis. It incorporates five independent predictors of mortality that can be easily assessed upon presentation:

1. Glasgow Coma Scale (GCS) score: A GCS of 3-4 scores 2 points, 5-12 scores 1 point, and 13-15 scores 0 points.
2. ICH volume: A volume greater than or equal to 30 cm³ scores 1 point; less than 30 cm³ scores 0 points.
3. Intraventricular Hemorrhage (IVH): The presence of IVH scores 1 point; absence scores 0 points.
4. Infratentorial origin: Origin in the brainstem or cerebellum scores 1 point; supratentorial origin scores 0 points.
5. Age: Age 80 years or older scores 1 point; less than 80 years scores 0 points.

A score of 0 is associated with a 30-day mortality of 0%, whereas a score of 5 or 6 predicts a mortality rate approaching 100%. Volume calculation is typically performed using the ABC/2 method on non-contrast CT head imaging, where A is the maximum diameter, B is the diameter perpendicular to A, and C is the number of CT slices containing hemorrhage multiplied by the slice thickness.

Acute Management and Blood Pressure Control

The initial management of ICH focuses on stabilizing the patient, securing the airway (especially if the GCS is 8 or lower), and preventing further hematoma expansion. Early hematoma expansion occurs in up to 30% of patients within the first 24 hours of symptom onset and is a major determinant of poor neurological outcomes and increased mortality.

Aggressive blood pressure control is paramount in the acute phase of ICH to minimize the mechanical stress on the ruptured vessel and reduce the risk of hematoma expansion. Current guidelines from the American Heart Association/American Stroke Association (AHA/ASA) recommend that for patients presenting with a systolic blood pressure (SBP) between 150 and 220 mm Hg and without contraindications to acute blood pressure treatment, acute lowering of SBP to a target of 140 mm Hg is safe and can be effective in improving functional outcomes. Continuous intravenous infusions of easily titratable antihypertensive agents, such as nicardipine, clevidipine, or labetalol, are heavily preferred over intermittent push doses to avoid wide fluctuations in blood pressure.

However, reducing SBP aggressively below 140 mm Hg is not generally recommended. Trials have shown it does not provide additional neurological benefit and may actually increase the risk of adverse renal events and critical hypoperfusion. Close neurological monitoring in a dedicated intensive care setting is essential during BP titration to detect any subtle signs of neurological deterioration, which could indicate hematoma expansion, worsening edema, or cerebral ischemia due to relative hypoperfusion.

Reversal of Anticoagulation

In patients with ICH related to oral anticoagulants, rapid reversal of the underlying coagulopathy is a critical, time-sensitive emergency intervention. For patients taking Vitamin K Antagonists (VKAs) like warfarin, administration of 4-factor Prothrombin Complex Concentrate (PCC) along with intravenous Vitamin K is strongly recommended over fresh frozen plasma (FFP) due to faster correction of the International Normalized Ratio (INR), lower total volume load, and reduced risk of transfusion reactions.

For patients on direct oral anticoagulants (DOACs), specific and highly effective reversal agents are now available. Idarucizumab is a monoclonal antibody fragment used to rapidly and completely reverse the effects of the direct thrombin inhibitor dabigatran. Andexanet alfa is an engineered decoy factor Xa molecule specifically designed to rapidly reverse the anticoagulant effects of direct factor Xa inhibitors such as rivaroxaban and apixaban.

Intracranial Pressure and Surgical Management

Management of elevated ICP is another fundamental cornerstone of acute ICH care. Standard general measures include elevating the head of the bed to 30 degrees, optimizing analgesia and sedation to reduce metabolic demand, maintaining normothermia, and ensuring adequate venous drainage by keeping the neck straight. Osmotic therapy with mannitol or hypertonic saline may be utilized for patients showing clinical signs of impending herniation or progressive ICP elevation that is refractory to basic measures.

External ventricular drainage (EVD) is crucial for patients who develop obstructive hydrocephalus, a frequent complication when the hemorrhage extends into the ventricular system. Surgical evacuation of the primary hematoma remains controversial for deep supratentorial ICH. The major STICH trials did not show a clear overall benefit of early surgical evacuation for most spontaneous supratentorial ICH patients. However, surgical decompression is definitively and strongly recommended for patients with cerebellar hemorrhage larger than 3 cm, or those who are experiencing neurological deterioration, brainstem compression, or hydrocephalus, as this can be life-saving and often leads to favorable functional recovery. Minimally invasive surgery (MIS) combined with thrombolytic irrigation is an area of active, intense research that is showing great promise in improving clot clearance and long-term functional outcomes without the morbidity of traditional open craniotomies.